Case Report
Published on 29 May 2020
Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.00771
- 6,540 views
- 3 citations



